Adipose-Silk Composite for Soft Tissue Replacement
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current soft tissue replacement methods face challenges with artificial fillers due to lack of metabolic activity, migration, and temporary effects, while transplanted tissue methods suffer from tissue volume loss and poor survival rates due to inadequate blood supply.
Innovation Solution
A composition comprising adipose tissue, silk fibroin, and specific compounds that promote new blood vessel formation, such as FGF-2 and VEGF, to enhance the survival and integration of transplanted tissue.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If artificial or alloplastic fillers are used for soft tissue replacement, then the procedure is simple and provides immediate volume, but the material lacks metabolic activity, does not become physiologically incorporated, and surrounding tissue and blood supply do not develop within the implanted material
Solution Approach 1:
The patent uses composite materials by combining adipose tissue (biological component with metabolic activity) with alloplastic fillers (synthetic component providing structural support and volume). This composite approach allows the material to provide immediate volume like traditional fillers while simultaneously supporting physiological incorporation and blood supply development through the living adipose tissue component.
Solution Approach 2:
The adipose tissue acts as an intermediary between the host body and the alloplastic filler. It provides a biological interface that facilitates blood supply development and physiological incorporation, while also serving as a carrier for the synthetic filler material, thereby resolving the contradiction between simplicity and physiological integration.
2Ease of manufacture
If artificial or alloplastic fillers are used, then the procedure is simple, but the fillers risk migration and/or extrusion from the implant site
Solution Approach 1:
The adipose tissue acts as a flexible biological containment structure that holds the alloplastic filler in place. This living tissue shell provides mechanical stability and prevents migration and extrusion of the filler material, while maintaining the simplicity of the injection procedure.
3Reliability
If transplanted tissue is used for soft tissue replacement, then physiological incorporation occurs, but loss of transplanted tissue volume over time as a result of resorption by the body is a major problem
Solution Approach 1:
The alloplastic filler component provides beforehand cushioning by maintaining structural volume and supporting the transplanted adipose tissue. This prevents the volume loss that would otherwise occur due to resorption of the biological tissue, while allowing physiological incorporation to proceed.
Solution Approach 2:
The patent changes the parameter composition of the implant by combining living adipose tissue with non-resorbable alloplastic filler. This parameter change ensures that while the biological component can be physiologically incorporated, the overall volume is maintained by the stable synthetic component that does not undergo resorption.
4Duration of action of stationary object
If long-term fillers are used, then lasting effects are achieved, but they induce a foreign body response resulting in formation of an avascular, fibrous capsule around the filler
Solution Approach 1:
The patent applies local quality by creating different microenvironments within the implant. The adipose tissue regions provide a biological, vascularized environment that prevents foreign body response, while the alloplastic filler regions provide long-term structural support. This local differentiation allows long-term duration without harmful fibrous encapsulation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution increases the survival rate of transplanted tissue by establishing an adequate blood supply, reducing tissue volume loss, and improving long-term integration and function, thereby addressing the limitations of existing methods.
Implementation Method 1
The growth of new blood vessels and associated vasculature or repair or remodeling of existing blood vessels and associated vasculature provides collateral circulation in and around an ischemic area, improves blood flow, and alleviates the symptoms caused by the ischemia.
Data Source
AI summary
The specification discloses compositions and methods for treating a soft tissue defect of an individual.